Regnault V, Rivat C, Schooneman F, Marcillier P, Michaely J P, Didelon J, Stoltz J F, Siadat M
INSERM U 284, Vandoeuvre-lès-Nancy.
Ann Med Interne (Paris). 1990;141(7):604-7.
An immunoadsorption system for lowering plasma cholesterol was optimized. Several polyclonal and monoclonal antibodies were compared and the best results were obtained with goat polyclonal antibodies. The optimum quantity of antibodies to be immobilized on the gel was 5 mg/ml. Taking into account two variables, i.e., 1) that the regeneration must be as complete as possible and, 2) that immunoadsorbents must be used several times without a loss of adsorption capacity, desorption was achieved with 0.3 M glycine adjusted to pH 2.8. Antibody release from the immunoadsorbent was determined and can be minimized by glutaraldehyde treatment of the immunoadsorbent. Each phase, adsorption and desorption, respectively, was well-defined and synchronized, so that two columns could be used in parallel in an automated procedure. The kinetics of plasma protein removal demonstrated the efficiency and the specificity of the procedure.
一种用于降低血浆胆固醇的免疫吸附系统得到了优化。比较了几种多克隆抗体和单克隆抗体,结果发现山羊多克隆抗体效果最佳。固定在凝胶上的抗体最佳量为5毫克/毫升。考虑到两个变量,即1)再生必须尽可能完全,以及2)免疫吸附剂必须能多次使用且吸附能力不损失,用pH值调至2.8的0.3 M甘氨酸实现了解吸。测定了抗体从免疫吸附剂上的释放情况,通过对免疫吸附剂进行戊二醛处理可将其降至最低。吸附和解吸这两个阶段分别定义明确且同步,因此两根柱子可在自动化程序中并行使用。血浆蛋白去除动力学证明了该程序的效率和特异性。